tiprankstipranks
Biolase (BIOL)
OTHER OTC:BIOL
US Market

Biolase (BIOL) Financial Statements

1,627 Followers

Biolase Financial Overview

Biolase's market cap is currently ―. The company's EPS TTM is $-20.549; its P/E ratio is >-0.01; Biolase is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 10.13M$ 10.92M$ 10.47M$ 14.05M$ 12.01M
Gross Profit$ 3.34M$ 3.75M$ 3.34M$ 3.60M$ 2.44M
EBIT$ -5.87M$ -3.97M$ -6.45M$ -8.36M$ -7.98M
EBITDA$ -5.08M$ -3.31M$ -6.19M$ -7.23M$ -7.86M
Net Income Common Stockholders$ -6.49M$ -4.59M$ -5.85M$ -9.43M$ -8.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.39M$ 7.81M$ 6.50M$ 4.18M$ 9.96M
Total Assets$ 34.35M$ 38.74M$ 41.94M$ 38.19M$ 42.87M
Total Debt$ 14.55M$ 15.10M$ 15.33M$ 15.05M$ 14.84M
Net Debt$ 8.16M$ 7.29M$ 8.83M$ 10.87M$ 4.88M
Total Liabilities$ 34.08M$ 32.86M$ 33.79M$ 33.30M$ 29.01M
Stockholders Equity$ -1.93M$ 332.00K$ 8.16M$ 4.89M$ 13.86M
Cash Flow-
Free Cash Flow$ -5.74M$ -2.77M$ -6.25M$ -6.07M$ -9.22M
Operating Cash Flow$ -5.94M$ -2.59M$ -5.66M$ -5.60M$ -6.55M
Investing Cash Flow$ 197.00K$ -182.00K$ -587.00K$ -444.00K$ -2.68M
Financing Cash Flow$ 5.65M$ 3.76M$ 8.51M$ -32.00K$ -214.00K
Currency in USD

Biolase Earnings and Revenue History

Biolase Debt to Assets

Biolase Cash Flow

Biolase Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis